The 15 references in paper O. Zhukova V., S. Kononova V., О. Жукова В., С. Кононова В. (2017) “Особенности клинико-экономической оценки терапии хронических заболеваний: несоответствие результатов классического фармакоэкономического и социально-экономического анализов // CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES” / spz:neicon:pharmacoeconomics:y:2017:i:2:p:44-52

1
Briskin B. S., Lomidze O. V. Remedium. 2005; 4: 30-35.
(check this in PDF content)
2
Economic evaluation of the effectiveness of drug therapy (pharmacoeconomic analysis). Ed. Prof. P. A. Vorobyev [Ekonomicheskaya otsenka effektivnosti lekarstvennoi terapii (farmakoekonomicheskii analiz). Pod red. prof. P. A. Vorob’eva (in Russian)]. Moscow. 2000; 80 s.
(check this in PDF content)
3
Renee J. G. Arnold., Boca Raton F. L. Pharmacoeconomics: From Theory to Practice (Drug Discovery). CRC Press. 2009; 263-273.
(check this in PDF content)
4
Zaitseva O. V., Murtazaeva O. A. Voprosy sovremennoi pediatrii. 2011; 10: 148-156.
(check this in PDF content)
5
Sharavii A. O., Smirnova S. V. Byulleten’ VSNTs SO RAMN. 2012; 3: 222-225.
(check this in PDF content)
6
Khelimskaya I. V., Alekseenko S. A. Dnevnik kazanskoi meditsinskoi shkoly. 2013; 1: 40-42.
(check this in PDF content)
7
Hartert T. V., Speroff T., Togias A. et al. Risk factors for recurrent asthma hospital visits and death among a population o f indigent older adults with asthma. Ann Allergy Asthma Immunol. 2002; 89: 467-73.
(check this in PDF content)
8
Kolbin A. S., Klimko N. N., Andreev B. V. Kachestvennaya klinicheskaya praktika. 2008; 2: 53-61.
(check this in PDF content)
9
Global strategy for the treatment and prevention of bronchial asthma (2012 revision). Translation from English. Ed. A. S. Belevsky [Global’naya strategiya lecheniya i profilaktiki bronkhial’noi astmy (peresmotr 2012 g.). Per. s angl. / Pod red. A. S. Belevskogo (in Russian)]. Moscow. 2012; 108 s.
(check this in PDF content)
10
Drobik O. S., Biteeva D. V. Meditsinskii sovet. 2014; 16: 12-16.
(check this in PDF content)
11
Zaitseva O. V. Meditsinskii sovet. 2013; 1: 34-41.
(check this in PDF content)
12
Shaporova N. L., Trofimov V. I., Marchenko V. N. Atmosfera. Pul’monologiya i allergologiya. 2013; 4: 3-6.
(check this in PDF content)
13
Bisgaard H., Zielen S., Garcia M. L. et al. Montelukast reduces asthma exacerbations in 2- to 5-year old children with intermittent asthma. Am. J. Respir. Crit. Care Med. 2005; 171 (4): 315-322.
(check this in PDF content)
14
Kulichenko T. V. Montelukast v lechenii allergicheskikh boleznei. Pediatricheskaya farmakologiya. 2006; 3 (4): 32-41.
(check this in PDF content)
15
Robertson C. F., Henry R. L., Mellis C. et al. Short course montelukast for intermittent asthma in children: the Pre-Empr Study. Presented at the American Thoracic Society International Conference. USA, [A53] Poster C71, May 2004.
(check this in PDF content)